JP2023549114A5 - - Google Patents
Info
- Publication number
- JP2023549114A5 JP2023549114A5 JP2023526960A JP2023526960A JP2023549114A5 JP 2023549114 A5 JP2023549114 A5 JP 2023549114A5 JP 2023526960 A JP2023526960 A JP 2023526960A JP 2023526960 A JP2023526960 A JP 2023526960A JP 2023549114 A5 JP2023549114 A5 JP 2023549114A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- population
- item
- treg
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063109811P | 2020-11-04 | 2020-11-04 | |
| US63/109,811 | 2020-11-04 | ||
| US202063121534P | 2020-12-04 | 2020-12-04 | |
| US202063121453P | 2020-12-04 | 2020-12-04 | |
| US202063121742P | 2020-12-04 | 2020-12-04 | |
| US63/121,742 | 2020-12-04 | ||
| US63/121,534 | 2020-12-04 | ||
| US63/121,453 | 2020-12-04 | ||
| PCT/US2021/058141 WO2022098926A1 (en) | 2020-11-04 | 2021-11-04 | Methods for allogeneic hematopoietic stem cell transplantation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549114A JP2023549114A (ja) | 2023-11-22 |
| JP2023549114A5 true JP2023549114A5 (enExample) | 2024-11-12 |
Family
ID=81457370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526960A Pending JP2023549114A (ja) | 2020-11-04 | 2021-11-04 | 同種造血幹細胞移植のための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230372393A1 (enExample) |
| EP (1) | EP4240346A4 (enExample) |
| JP (1) | JP2023549114A (enExample) |
| AU (1) | AU2021373797A1 (enExample) |
| CA (1) | CA3197122A1 (enExample) |
| WO (1) | WO2022098926A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3012854T3 (en) | 2018-02-08 | 2025-04-10 | Univ Leland Stanford Junior | Allogenic hematopoietic stem cell transplantation |
| EP4426318A4 (en) * | 2021-11-04 | 2025-11-19 | Orca Biosystems Inc | THERAPEUTIC COMPOSITIONS AND TRANSPLANTATION PROCESSES OF ALLOGENEIC HEMATOPOIETIC CELLS |
| AU2023252879A1 (en) * | 2022-04-15 | 2024-11-21 | Orca Biosystems, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
| EP4611778A4 (en) * | 2022-11-03 | 2026-07-15 | Orca Biosystems Inc | COMPOSITION AND METHODS FOR HEMATOPOIETIC STEM CELL TRANSPLANTS |
| WO2025054336A1 (en) * | 2023-09-05 | 2025-03-13 | Orca Biosystems, Inc. | Compositions and methods for treating cancer using cell therapies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11534460B2 (en) * | 2015-05-11 | 2022-12-27 | University Health Network | Method for expansion of double negative regulatory T cells |
| WO2018106610A1 (en) * | 2016-12-05 | 2018-06-14 | The Regents Of The University Of California | Immunomagnetic bead-based method to enrich stem cells from whole hematopoietic tissue |
| CN118662615A (zh) * | 2017-03-15 | 2024-09-20 | 浩康生物系统公司 | 用于造血干细胞移植的组合物和方法 |
| ES3012854T3 (en) * | 2018-02-08 | 2025-04-10 | Univ Leland Stanford Junior | Allogenic hematopoietic stem cell transplantation |
-
2021
- 2021-11-04 AU AU2021373797A patent/AU2021373797A1/en active Pending
- 2021-11-04 EP EP21890102.3A patent/EP4240346A4/en active Pending
- 2021-11-04 JP JP2023526960A patent/JP2023549114A/ja active Pending
- 2021-11-04 CA CA3197122A patent/CA3197122A1/en active Pending
- 2021-11-04 WO PCT/US2021/058141 patent/WO2022098926A1/en not_active Ceased
-
2023
- 2023-05-02 US US18/142,513 patent/US20230372393A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2736802C2 (ru) | Новое лечение острого лимфобластного лейкоза у детей | |
| Yan et al. | Sequential CD19 and BCMA‐specific CAR T‐cell treatment elicits sustained remission of relapsed and/or refractory myeloma | |
| Zhou et al. | Phase I trial of fourth-generation anti-CD19 chimeric antigen receptor T cells against relapsed or refractory B cell non-Hodgkin lymphomas | |
| AU2020380366B2 (en) | Chimeric antigen receptor T cell therapy | |
| Brett et al. | Repopulation of blood lymphocyte sub‐populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH‐1H | |
| Alexia et al. | Polyoxidonium® activates cytotoxic lymphocyte responses through dendritic cell maturation: clinical effects in breast cancer | |
| JP7652949B2 (ja) | 同種造血幹細胞移植のための方法 | |
| CN104093314A (zh) | 使用针对t/b细胞耗尽的特异性方案的用于稳定和长期植入的联合疗法 | |
| Nakazawa et al. | Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors | |
| US20240115617A1 (en) | Cellular compositions derived from prior organ donors and methods of manufacture and use thereof | |
| Dreyzin et al. | CD123‐targeting immunotherapeutic approaches in acute myeloid leukaemia | |
| O’Neal et al. | Traversing the bench to bedside journey for iNKT cell therapies | |
| Zhao et al. | Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress | |
| US20230201256A1 (en) | Calcineurin inhibitor to improve cd3+cell survival to thereby facilitate engraftment of donor cd34+ cells in a recipient | |
| Medina et al. | A pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies | |
| JP2026508791A (ja) | 免疫療法の有効性及び永続的奏効の改善 | |
| TWI837437B (zh) | 嵌合抗原受體t細胞療法 | |
| US20100129329A1 (en) | METHODS FOR USING ALDHbr CELLS TO SUPPLEMENT STEM CELL TRANSPLANTATION | |
| US20100111905A1 (en) | Methods for improved engraftment following stem cell transplantation | |
| Stenger et al. | Use of alefacept for preconditioning in multiply transfused pediatric patients with nonmalignant diseases | |
| Dai et al. | A successful haploidentical transplantation without conditioning regimen for a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T-cell therapy | |
| Russell et al. | Allogeneic transplantation using peripheral blood stem cells | |
| Guerettaz et al. | High affinity CD16v/v allogeneic NK cell therapy, AB-101, enhances antibody-mediated cytotoxicity in B-cell driven diseases | |
| Giménez et al. | Intrathecal liposomal cytarabine (DepoCyte®) as treatment for CNS infiltration in an adult woman with acute myeloid leukaemia | |
| Lutz et al. | Acute leukaemia |